Clinical CRC diagnostics utilize blood markers like carcinoembryonic antigen (CEA) and guaiac-based fecal occult blood test (gFOBT), which suffer from low sensitivity and specificity 10. This evidence concerns the gene CEACAM5 and colorectal carcinoma.